Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Related Citations for PubMed (Select 17260013)

1.

SPARC enhances tumor stroma formation and prevents fibroblast activation.

Chlenski A, Guerrero LJ, Yang Q, Tian Y, Peddinti R, Salwen HR, Cohn SL.

Oncogene. 2007 Jul 5;26(31):4513-22. Epub 2007 Jan 29.

PMID:
17260013
2.

SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.

Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL.

Int J Cancer. 2006 Jan 15;118(2):310-6.

PMID:
16052522
3.

SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.

Prada F, Benedetti LG, Bravo AI, Alvarez MJ, Carbone C, Podhajcer OL.

J Invest Dermatol. 2007 Nov;127(11):2618-28. Epub 2007 Jul 12.

4.

An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.

Gotoh N, Perdue NR, Matsushima H, Sage EH, Yan Q, Clark JI.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4679-87.

5.
6.

A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer.

Wu MP, Young MJ, Tzeng CC, Tzeng CR, Huang KF, Wu LW, Chou CY.

Carcinogenesis. 2008 Jun;29(6):1115-23. doi: 10.1093/carcin/bgn077. Epub 2008 Apr 15.

7.
8.

SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.

Haber CL, Gottifredi V, Llera AS, Salvatierra E, Prada F, Alonso L, Sage EH, Podhajcer OL.

Int J Cancer. 2008 Apr 1;122(7):1465-75. Erratum in: Int J Cancer. 2008 Jul 1;123(1):245. Helene, Sage E [corrected to Sage, E Helene].

PMID:
18059024
9.
10.

Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.

Seno T, Harada H, Kohno S, Teraoka M, Inoue A, Ohnishi T.

Int J Oncol. 2009 Mar;34(3):707-15.

PMID:
19212676
11.

Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation.

Bradshaw AD, Francki A, Motamed K, Howe C, Sage EH.

Mol Biol Cell. 1999 May;10(5):1569-79.

12.

Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.

Iruela-Arispe ML, Vernon RB, Wu H, Jaenisch R, Sage EH.

Dev Dyn. 1996 Oct;207(2):171-83.

13.

Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.

Reed MJ, Bradshaw AD, Shaw M, Sadoun E, Han N, Ferara N, Funk S, Puolakkainen P, Sage EH.

J Cell Physiol. 2005 Sep;204(3):800-7.

PMID:
15795937
14.

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A, Yang Q, Salwen HR, Farrer R, Bray J, Cohn SL.

Cancer Res. 2002 Dec 15;62(24):7357-63.

15.

Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.

Yang F, Strand DW, Rowley DR.

Oncogene. 2008 Jan 17;27(4):450-9. Epub 2007 Jul 16.

PMID:
17637743
16.

The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.

Said N, Frierson HF Jr, Chernauskas D, Conaway M, Motamed K, Theodorescu D.

Oncogene. 2009 Oct 1;28(39):3487-98. doi: 10.1038/onc.2009.205. Epub 2009 Jul 13.

PMID:
19597474
17.

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M.

J Clin Oncol. 2007 Jan 20;25(3):319-25.

18.

Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.

Sage EH, Bassuk JA, Yost JC, Folkman MJ, Lane TF.

J Cell Biochem. 1995 Jan;57(1):127-40.

PMID:
7721952
19.

Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.

Kato Y, Tsukuda M, Nagashima Y, Koshika S, Sakai N, Yao M, Kubota Y, Aoki I, Colledge WH, Foidart JM, Hata R, Thompson EW.

Int J Oncol. 2005 Sep;27(3):759-68.

PMID:
16077926
20.

A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.

Clark CJ, Sage EH.

J Cell Biochem. 2008 Jun 1;104(3):721-32. doi: 10.1002/jcb.21688. Review.

PMID:
18253934
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk